4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000025
President and CEO acquired 4,654,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Brunn Carsten · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-02 | Grant or award : show line 1 in the form | +4,654,100 | 4,916,056 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-02 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +5,971,000 | 5,971,000 | D |
Loading xslF345X05/wk-form4_1704406045.xml…